Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Immatics Biotechnologies GmbH
DescriptionVaccine containing tumor-associated peptides (TUMAPs)
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase III
Standard IndicationRenal cancer
Indication DetailsTreat renal cell carcinoma (RCC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today